Muscle Energy Technique Versus Mulligan Mobilization on Forward Head Posture

December 12, 2024 updated by: Mariam Nazih Radwan Meshref, Cairo University

Muscle Energy Technique Versus Mulligan Mobilization on Forward Head Posture: a Randomized Controlled Trial

sixty patients with forward head posture will be randomized to three groups Group A: will receive traditional treatment ( isometric exercise for deep neck flexors plus sub occipital release).

Group B: will receive traditional treatment plus muscle energy technique for upper trapezius, elevator scapulae and sternocleidomastoid.

Group C: will receive traditional treatment plus mulligan mobilization

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Radwa fayek Lecturer at Basic Science Department MTI University, Doctoral
  • Phone Number: 02-01004466229
  • Email: radwa26fayek@yahoo.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 18 to 45 years
  • Non specific neck pain reproduced by neck movement
  • Neck pain at least within the last three months
  • Limitation in cervical range of motion

Exclusion Criteria:

  • cervical spine surgery or injury
  • neurologic deficits, infection or inflammation
  • cervicogenic headache

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Group A: Control group (Traditional treament)
patients will receive traditional treatment (isometric exercise for deep neck flexors plus sub occipital release).
Isometric exercise for deep neck flexors and sub occipital release
Experimental: Group B (muscle energy technique group)
Patients will receive muscle energy Technique for upper trapezius, elevator scapulae and sternocleidomastoid
Isometric exercise for deep neck flexors and sub occipital release
Muscle energy technique for upper trapezius, elevator scapulae and sternocleidomastoid
Active Comparator: Group C (Mulligan Mobilization Group)
Patients will receive Mulligan mobilization
Isometric exercise for deep neck flexors and sub occipital release
Mulligan mobilization in the form of SNAGS for rotation, lateral flexion, extension and flexion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain
Time Frame: Before the first session and at the end of the treatment program ( one month)
Pain will be measured by visual analogue scale which is a valid and reliable scale for measuring pain starts with zero (represents no pain) and ends with 10 (represents maximum pain).
Before the first session and at the end of the treatment program ( one month)
Cervical range of motion
Time Frame: Before the first session and after the end of the treatment program ( one month)
Cervical range of motion in will be measured by cervical range of motion basic assessment device (CROM) the angle of cervical range of motion will be recorded in degrees to determine the limitation in range of motion
Before the first session and after the end of the treatment program ( one month)
Disability measurement
Time Frame: Before the first session and after the end of the treatment program ( one month)

Disability will be measured by neck disability index(NDI) is a valid and reliable scale.

The NDI consists of ten questions in the following domains: Pain Intensity, Personal Care, Lifting, Reading, Headaches, Concentration, Work, Driving, Sleeping, and Recreation.

Scoring: Each question contains six answer choices, scored from 0 (no disability) to 5 (complete disability). All section scores are then totaled. Scoring is reported on a 0-50 scale, 0 being the best possible score and 50 being the worst. Alternately, the score can be reported from 0-100. The score is often reported as a percentage (0-100%).

Before the first session and after the end of the treatment program ( one month)
Cervicovertebral angle
Time Frame: Before the first session and after the end of the treatment program ( one month)

Cervicovertebral angle (CVA) Will be measure by kinovea:

Normal range is between 55 and 86, If the angle is less than 50 degrees, it will be considered to be FHP. Adhesive markers (8 mm in diameter) will be placed on the participant's C7 spinous process and tragus of the ear. The physical therapist will observe the participant from the lateral side while standing and then take a picture of the participant from a fixed distance (75 cm) and height (150 cm), then with the help of an application sealed by a password which is called KINOVEA, the angle will be measured by placing each vector as following a line from the tragus of the ear to the C7 spinous process and another horizontal line through the C7 spinous. The angle will be recorded in degrees

Before the first session and after the end of the treatment program ( one month)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2024

Primary Completion (Estimated)

February 1, 2025

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

December 7, 2024

First Submitted That Met QC Criteria

December 12, 2024

First Posted (Estimated)

December 13, 2024

Study Record Updates

Last Update Posted (Estimated)

December 13, 2024

Last Update Submitted That Met QC Criteria

December 12, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/005077

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe